CCL2-decorated EVs directly targeted CCR2 receptor expressed on the membrane of tumor associated macrophages and promotes lymphangiogenesis through inducing VEGF-C section by tumor associated macrophages3,7. The gene discussed is VEGFC; the disease is neoplasm.